维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Everly MJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Durability of antibody removal following proteasome inhibitor-based therapy显示文摘	Everly MJ Terasaki PI Trivedi HL		0，，06：	1
2	Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection显示文摘	Everly MJ Everly JJ Susskind B	2008	Transplantation2008，，12：	1
3	Reducing de novo do nor-specific antibody levels during acute rejection diminishes renal allograft loss显示文摘	Everly MJ Everly JJ Arend LJ		0，，05：	1
4	Bortezomib provides effective therapy for antibody and cell-mediated acute rejection 显示文摘	Everly MJ Everly JJ Susskind B	2008	Transplantation2008，86，12：	1
5	Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection显示文摘	Everly MJ Everly JJ Susskind B	2008	Transplantation2008，86，12：	1
6	Beta-blocker underuse in secondary prevention of myocardial infarction显示文摘	Everly MJ Heaton PC Cluxton RJ Jr	2004	Ann Pharmacother2004，38，2：	1
7	Bortezomib provideseffective therapy for antibody-and cell-mediated acute rejection显示文摘	Everly MJ Everly JJ Susskind B	2008	Transplantation2008，86，12：	1
8	Donor risk factors in orthotopie liver trans- plant: analysis of the OPTN/UNOS registry显示文摘	Kawakita S Everly MJ	2013	Clin Transpl2013，，：	1
9	Beta-blocker underuse in secondary prevention of myocardial infarction显示文摘	Everly MJ Heaton PC Cluxton RJ Jr	2004	Ann Pharmacother2004，38，2：	1
10	Protective immunity remains intact after antibody removal bymeans of proteasome inhibition显示文摘	Everly MJ Terasaki PI Hopfield J	2010	Transplantation2010，90，12：	1
11	Using HLA antibody detection, monitoring, and treatment to improve long - term allograft survival 显示文摘	Everly MJ	2010	Clin Transpl2010，，：	1
12	Beyond histology:lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection显示文摘	Everly MJ Rebellato LM Ozawa M		0，，08：	1
13	Bortezomib provides effective therapy for antibody- and cel -mediated acute rejection显示文摘	Everly MJ Everly JJ Susskind B		0，，12：	1
14	Using donor- specific antibodies to monitor the need for immuno- suppression显示文摘	Hoshino J Kaneku H Everly MJ	2012	Transplantation2012，93，11：	1
15	Elimination of post-transplant donor-specific HLA antibodies with bortezomib显示文摘	Idica A Kaneku H Everly MJ		0，，：	1
16	A summary of bortezomib use in transplantation across 29 centers显示文摘	Everly MJ		0，，：	1
17	Beta-blocker tmderuse in sec- ondary prevention of myocardial infarction 显示文摘	Everly MJ Heaton PC Cluxton RJ Jr	2004	Ann Pharmacother2004，38，2：	1
18	Incidence and impact of de novo donor-specific alloantibody in primary renal allografts 显示文摘	Everly MJ Rebellato LM Haisch CE	2013	Trans- plantation2013，95，3：	1
19	The state of therapy for removal of al oantibody producing plasma cel s in transplantation显示文摘	Everly MJ Terasaki PI		0，，02：	1
20	Bortezomib provides effective therapy for antibody-and cell-mediated acute rejection显示文摘	Everly MJ Everly JJ Susskind B		0，，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示